Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Injectable Platelet-rich Fibrin and Platelet-Rich Plasma in Treatment of Diabetic Patients with Stage Ⅱ Grade C Periodontitis (Clinical and Microbiological Study).

NCT06685393 is registered in ClinicalTrials.gov with ELsabbahy Ahmed Mohamed Youssef as lead sponsor.

NCT NCT06685393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06685393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Injectable Platelet-rich Fibrin and Platelet-Rich Plasma in Treatment of Diabetic Patients with Stage Ⅱ Grade C Periodontitis (Clinical and Microbiological Study).
Lead sponsor
ELsabbahy Ahmed Mohamed Youssef
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2023
Completion date
March 25, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peridontal disease